nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—SHBG—Nongenotropic Androgen signaling—GNAO1—epilepsy syndrome	0.0581	0.0659	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—PLCB1—epilepsy syndrome	0.033	0.0374	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—CDC42—epilepsy syndrome	0.0281	0.0319	CbGpPWpGaD
Drostanolone—Ursodeoxycholic acid—SLCO1A2—epilepsy syndrome	0.0257	0.258	CrCbGaD
Drostanolone—CYP19A1—Tryptophan metabolism—WARS—epilepsy syndrome	0.0242	0.0275	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—SNIP1—epilepsy syndrome	0.0236	0.0268	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—ASCL1—epilepsy syndrome	0.021	0.0238	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—FOS—epilepsy syndrome	0.0181	0.0205	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—GNAO1—epilepsy syndrome	0.018	0.0204	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.014	0.0159	CbGpPWpGaD
Drostanolone—CYP19A1—Endogenous sterols—CYP11A1—epilepsy syndrome	0.0138	0.0157	CbGpPWpGaD
Drostanolone—Ursodeoxycholic acid—ABCC2—epilepsy syndrome	0.0123	0.124	CrCbGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—SRC—epilepsy syndrome	0.0117	0.0132	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CACNA1G—epilepsy syndrome	0.0116	0.0132	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.0113	0.0128	CbGpPWpGaD
Drostanolone—Methyltestosterone—SLCO1A2—epilepsy syndrome	0.0105	0.105	CrCbGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—UBE3A—epilepsy syndrome	0.0105	0.0119	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—epilepsy syndrome	0.0104	0.0117	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—PLCB1—epilepsy syndrome	0.0102	0.0116	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—TCF4—epilepsy syndrome	0.00876	0.00994	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—CDC42—epilepsy syndrome	0.00869	0.00986	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.00831	0.00943	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.00803	0.00911	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.00803	0.00911	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—BDNF—epilepsy syndrome	0.00797	0.00904	CbGpPWpGaD
Drostanolone—Medrysone—NR3C1—epilepsy syndrome	0.00786	0.0789	CrCbGaD
Drostanolone—AR—Androgen receptor signaling pathway—UBE3A—epilepsy syndrome	0.00773	0.00877	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—FLNA—epilepsy syndrome	0.00762	0.00865	CbGpPWpGaD
Drostanolone—Estradiol—SLCO1A2—epilepsy syndrome	0.00757	0.076	CrCbGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—AKT1—epilepsy syndrome	0.00724	0.00822	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—epilepsy syndrome	0.00706	0.00801	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—VDR—epilepsy syndrome	0.00691	0.00784	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—VDR—epilepsy syndrome	0.00682	0.00774	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—PTK2B—epilepsy syndrome	0.00664	0.00754	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.00646	0.00733	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.00642	0.00728	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—TSC2—epilepsy syndrome	0.00639	0.00725	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.00637	0.00723	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.00633	0.00719	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.00624	0.00708	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—NR3C1—epilepsy syndrome	0.00622	0.00706	CbGpPWpGaD
Drostanolone—CYP19A1—Endogenous sterols—POMC—epilepsy syndrome	0.00611	0.00693	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.00608	0.0069	CbGpPWpGaD
Drostanolone—Testosterone—SLCO1A2—epilepsy syndrome	0.00607	0.0609	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	0.00581	0.00659	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.00579	0.00657	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.00572	0.00649	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—HES1—epilepsy syndrome	0.0057	0.00647	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—FOS—epilepsy syndrome	0.0056	0.00636	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.00556	0.00631	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.00556	0.00631	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	0.00546	0.0062	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	0.00546	0.00619	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—SIRT1—epilepsy syndrome	0.00537	0.0061	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.00536	0.00608	CbGpPWpGaD
Drostanolone—Testosterone—CYP11A1—epilepsy syndrome	0.00528	0.053	CrCbGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—ATM—epilepsy syndrome	0.00526	0.00597	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—CAT—epilepsy syndrome	0.00526	0.00597	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.00523	0.00594	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.0052	0.0059	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.00517	0.00587	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—NR3C1—epilepsy syndrome	0.00492	0.00558	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—NR3C1—epilepsy syndrome	0.00477	0.00541	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.0047	0.00533	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—epilepsy syndrome	0.00458	0.00519	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—KDR—epilepsy syndrome	0.00457	0.00519	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.0044	0.00499	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.0044	0.00499	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—MTOR—epilepsy syndrome	0.00433	0.00491	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—FOS—epilepsy syndrome	0.00423	0.0048	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.00414	0.00469	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	0.00377	0.00428	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CDC42—epilepsy syndrome	0.00374	0.00424	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.00371	0.00421	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—SRC—epilepsy syndrome	0.00361	0.00409	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	0.00357	0.00405	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—SIRT1—epilepsy syndrome	0.00355	0.00403	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	0.00352	0.00399	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	0.00352	0.00399	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAZ—epilepsy syndrome	0.00348	0.00395	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—SRC—epilepsy syndrome	0.00347	0.00393	CbGpPWpGaD
Drostanolone—SHBG—hindbrain—epilepsy syndrome	0.00341	0.179	CbGeAlD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—epilepsy syndrome	0.0034	0.00385	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.00337	0.00382	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.00324	0.00367	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.00324	0.00367	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	0.00322	0.00365	CbGpPWpGaD
Drostanolone—Estradiol—ABCG2—epilepsy syndrome	0.0032	0.0321	CrCbGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CASP8—epilepsy syndrome	0.00318	0.00361	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.00313	0.00356	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.00305	0.00346	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.00305	0.00346	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—JUN—epilepsy syndrome	0.00304	0.00345	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.00304	0.00344	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	0.00284	0.00322	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.00279	0.00317	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP2C19—epilepsy syndrome	0.00278	0.00316	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	0.00277	0.00314	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP11A1—epilepsy syndrome	0.00276	0.00314	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.00274	0.00311	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.00273	0.00309	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	0.00262	0.00297	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	0.0026	0.00295	CbGpPWpGaD
Drostanolone—Testosterone—ABCG2—epilepsy syndrome	0.00257	0.0258	CrCbGaD
Drostanolone—Estradiol—CYP2C19—epilepsy syndrome	0.00252	0.0252	CrCbGaD
Drostanolone—CYP19A1—Biological oxidations—CYP2D6—epilepsy syndrome	0.00249	0.00283	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.00246	0.00279	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.00245	0.00278	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	0.00245	0.00278	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	0.00239	0.00272	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	0.00235	0.00267	CbGpPWpGaD
Drostanolone—Progesterone—NR3C1—epilepsy syndrome	0.00234	0.0235	CrCbGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	0.00233	0.00264	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.00231	0.00262	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	0.0023	0.00261	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.00228	0.00258	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.00224	0.00255	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—AKT1—epilepsy syndrome	0.00224	0.00254	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.00218	0.00248	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.00216	0.00245	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—AKT1—epilepsy syndrome	0.00215	0.00244	CbGpPWpGaD
Drostanolone—AR—Gene Expression—WARS—epilepsy syndrome	0.00215	0.00244	CbGpPWpGaD
Drostanolone—Progesterone—CYP2C19—epilepsy syndrome	0.00213	0.0214	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.00211	0.0024	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	0.00211	0.00239	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.00204	0.00232	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.00202	0.00229	CbGpPWpGaD
Drostanolone—Testosterone—CYP2C19—epilepsy syndrome	0.00202	0.0203	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	0.00201	0.00228	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	0.002	0.00227	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—RELA—epilepsy syndrome	0.00197	0.00224	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.00196	0.00223	CbGpPWpGaD
Drostanolone—SHBG—brainstem—epilepsy syndrome	0.00196	0.103	CbGeAlD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	0.00194	0.0022	CbGpPWpGaD
Drostanolone—Methyltestosterone—ALB—epilepsy syndrome	0.00193	0.0194	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	0.00193	0.00219	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.00192	0.00218	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	0.0019	0.00216	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CA13—epilepsy syndrome	0.0019	0.00216	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—epilepsy syndrome	0.00188	0.00214	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	0.00187	0.00213	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	0.00187	0.00212	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—epilepsy syndrome	0.00183	0.00208	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	0.00177	0.002	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—JUN—epilepsy syndrome	0.00173	0.00196	CbGpPWpGaD
Drostanolone—AR—Gene Expression—QARS—epilepsy syndrome	0.00163	0.00185	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	0.00161	0.00183	CbGpPWpGaD
Drostanolone—Progesterone—CYP2D6—epilepsy syndrome	0.00158	0.0159	CrCbGaD
Drostanolone—AR—Androgen receptor signaling pathway—SRC—epilepsy syndrome	0.00155	0.00176	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	0.00154	0.00175	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.00153	0.00174	CbGpPWpGaD
Drostanolone—CYP19A1—forebrain—epilepsy syndrome	0.00153	0.0804	CbGeAlD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	0.00152	0.00172	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	0.00146	0.00166	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GLUD1—epilepsy syndrome	0.00144	0.00164	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CERS1—epilepsy syndrome	0.00144	0.00164	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PDXK—epilepsy syndrome	0.00144	0.00164	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—FAR1—epilepsy syndrome	0.00144	0.00164	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ADK—epilepsy syndrome	0.00144	0.00164	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—L2HGDH—epilepsy syndrome	0.00144	0.00164	CbGpPWpGaD
Drostanolone—Estradiol—ALB—epilepsy syndrome	0.0014	0.014	CrCbGaD
Drostanolone—AR—forebrain—epilepsy syndrome	0.00135	0.0712	CbGeAlD
Drostanolone—Estradiol—ABCB1—epilepsy syndrome	0.00133	0.0134	CrCbGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	0.00133	0.00151	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	0.00132	0.0015	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—EPM2A—epilepsy syndrome	0.00132	0.0015	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NHLRC1—epilepsy syndrome	0.00132	0.0015	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GAMT—epilepsy syndrome	0.00132	0.0015	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PNPO—epilepsy syndrome	0.00132	0.0015	CbGpPWpGaD
Drostanolone—AR—Gene Expression—EIF2B5—epilepsy syndrome	0.00131	0.00148	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—AKT1—epilepsy syndrome	0.0013	0.00148	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	0.00128	0.00145	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	0.00127	0.00144	CbGpPWpGaD
Drostanolone—AR—telencephalon—epilepsy syndrome	0.00125	0.0655	CbGeAlD
Drostanolone—CYP19A1—Metabolism—CA4—epilepsy syndrome	0.00123	0.00139	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—QDPR—epilepsy syndrome	0.00123	0.00139	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—POMC—epilepsy syndrome	0.00122	0.00139	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—JUNB—epilepsy syndrome	0.00119	0.00135	CbGpPWpGaD
Drostanolone—AR—Gene Expression—TFAM—epilepsy syndrome	0.00118	0.00134	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	0.00117	0.00132	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	0.00115	0.00131	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—COX3—epilepsy syndrome	0.00115	0.00131	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	0.00114	0.00129	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	0.00114	0.00129	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	0.00114	0.00129	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	0.00113	0.00129	CbGpPWpGaD
Drostanolone—Progesterone—ABCB1—epilepsy syndrome	0.00113	0.0113	CrCbGaD
Drostanolone—Testosterone—ALB—epilepsy syndrome	0.00112	0.0112	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	0.0011	0.00125	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	0.0011	0.00124	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—KCNB1—epilepsy syndrome	0.00109	0.00124	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PFKL—epilepsy syndrome	0.00109	0.00124	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLCO1A2—epilepsy syndrome	0.00109	0.00124	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CACNA2D2—epilepsy syndrome	0.00109	0.00124	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC6A8—epilepsy syndrome	0.00109	0.00124	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	0.00109	0.00124	CbGpPWpGaD
Drostanolone—Testosterone—ABCB1—epilepsy syndrome	0.00107	0.0107	CrCbGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.00107	0.00121	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.00106	0.0012	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	0.00104	0.00118	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	0.00104	0.00118	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SNRPE—epilepsy syndrome	0.00102	0.00116	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	0.001	0.00114	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NEU1—epilepsy syndrome	0.000999	0.00113	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ATIC—epilepsy syndrome	0.000999	0.00113	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—UPB1—epilepsy syndrome	0.000999	0.00113	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	0.00099	0.00112	CbGpPWpGaD
Drostanolone—SHBG—central nervous system—epilepsy syndrome	0.000987	0.0518	CbGeAlD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	0.000975	0.00111	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	0.000967	0.0011	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	0.000965	0.00109	CbGpPWpGaD
Drostanolone—SHBG—cerebellum—epilepsy syndrome	0.000964	0.0507	CbGeAlD
Drostanolone—AR—Androgen receptor signaling pathway—AKT1—epilepsy syndrome	0.000964	0.00109	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HSD17B4—epilepsy syndrome	0.000962	0.00109	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—VDR—epilepsy syndrome	0.000943	0.00107	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	0.000939	0.00107	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPP1R3C—epilepsy syndrome	0.000929	0.00105	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GBE1—epilepsy syndrome	0.000929	0.00105	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000908	0.00103	CbGpPWpGaD
Drostanolone—CYP19A1—head—epilepsy syndrome	0.000876	0.046	CbGeAlD
Drostanolone—CYP19A1—Metabolism—ASAH1—epilepsy syndrome	0.000873	0.000991	CbGpPWpGaD
Drostanolone—AR—spinal cord—epilepsy syndrome	0.000873	0.0459	CbGeAlD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	0.000852	0.000967	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—STXBP1—epilepsy syndrome	0.00085	0.000964	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NR3C1—epilepsy syndrome	0.000849	0.000964	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	0.000842	0.000956	CbGpPWpGaD
Drostanolone—CYP19A1—nervous system—epilepsy syndrome	0.000831	0.0437	CbGeAlD
Drostanolone—CYP19A1—Metabolism—NT5E—epilepsy syndrome	0.000828	0.000939	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ALAD—epilepsy syndrome	0.000828	0.000939	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	0.000827	0.000938	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	0.00082	0.000931	CbGpPWpGaD
Drostanolone—CYP19A1—central nervous system—epilepsy syndrome	0.0008	0.042	CbGeAlD
Drostanolone—CYP19A1—Metabolism—ALDH7A1—epilepsy syndrome	0.00079	0.000896	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CACNA1A—epilepsy syndrome	0.00079	0.000896	CbGpPWpGaD
Drostanolone—SHBG—brain—epilepsy syndrome	0.000783	0.0412	CbGeAlD
Drostanolone—AR—head—epilepsy syndrome	0.000776	0.0408	CbGeAlD
Drostanolone—CYP19A1—Metabolism—ST3GAL3—epilepsy syndrome	0.000773	0.000877	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ADSL—epilepsy syndrome	0.000757	0.000859	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GLUL—epilepsy syndrome	0.000743	0.000843	CbGpPWpGaD
Drostanolone—AR—nervous system—epilepsy syndrome	0.000735	0.0386	CbGeAlD
Drostanolone—CYP19A1—Metabolism—CACNA1D—epilepsy syndrome	0.000729	0.000827	CbGpPWpGaD
Drostanolone—AR—Gene Expression—EIF2S1—epilepsy syndrome	0.000711	0.000806	CbGpPWpGaD
Drostanolone—AR—central nervous system—epilepsy syndrome	0.000708	0.0372	CbGeAlD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	0.000703	0.000798	CbGpPWpGaD
Drostanolone—AR—Gene Expression—HSPB1—epilepsy syndrome	0.000686	0.000778	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TXNRD1—epilepsy syndrome	0.000682	0.000774	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AQP1—epilepsy syndrome	0.000662	0.000751	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000636	0.000721	CbGpPWpGaD
Drostanolone—CYP19A1—brain—epilepsy syndrome	0.000635	0.0334	CbGeAlD
Drostanolone—AR—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	0.000632	0.000717	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CHRM3—epilepsy syndrome	0.000599	0.000679	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—KCNJ11—epilepsy syndrome	0.000599	0.000679	CbGpPWpGaD
Drostanolone—AR—Gene Expression—JUNB—epilepsy syndrome	0.000572	0.000649	CbGpPWpGaD
Drostanolone—AR—brain—epilepsy syndrome	0.000562	0.0295	CbGeAlD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000557	0.000632	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000546	0.00062	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	0.000544	0.000617	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	0.000523	0.000594	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ABCG2—epilepsy syndrome	0.000488	0.000554	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP2C19—epilepsy syndrome	0.000476	0.00054	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP11A1—epilepsy syndrome	0.000473	0.000536	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000469	0.000532	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SIRT1—epilepsy syndrome	0.000461	0.000523	CbGpPWpGaD
Drostanolone—AR—Gene Expression—VDR—epilepsy syndrome	0.000454	0.000515	CbGpPWpGaD
Drostanolone—AR—Gene Expression—H2AFX—epilepsy syndrome	0.000431	0.000489	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.000428	0.000485	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	0.000427	0.000484	CbGpPWpGaD
Drostanolone—AR—Gene Expression—YWHAZ—epilepsy syndrome	0.000415	0.000471	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NR3C1—epilepsy syndrome	0.000409	0.000464	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	0.000406	0.000461	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—BCHE—epilepsy syndrome	0.000404	0.000459	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	0.000386	0.000438	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	0.000382	0.000433	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TH—epilepsy syndrome	0.00038	0.000431	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	0.000374	0.000425	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	0.000317	0.00036	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CAT—epilepsy syndrome	0.000313	0.000355	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	0.000305	0.000346	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GPX1—epilepsy syndrome	0.000283	0.000321	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AGT—epilepsy syndrome	0.000248	0.000282	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—APOE—epilepsy syndrome	0.000243	0.000276	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—POMC—epilepsy syndrome	0.000209	0.000237	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ALB—epilepsy syndrome	0.000191	0.000216	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	0.000167	0.000189	CbGpPWpGaD
Drostanolone—AR—Gene Expression—AKT1—epilepsy syndrome	0.000125	0.000142	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKT1—epilepsy syndrome	8.38e-05	9.5e-05	CbGpPWpGaD
